TABLE 3.
Acute rejection | Early PBC | Chronic rejection | Late PBC | |
---|---|---|---|---|
Portal/septal inflammation | ||||
Intensity | +++ | +++ | + | ++ |
Naturea | L, but mixed | L, G, P | L, P | L, P, G |
Bile duct lesion | ||||
Presence | ++ | ++ | +++ | + |
Sizeb | S, M, L | M, S | S, M, L | M, S |
Bile duct loss | 0 | 0 | +++ | +++ |
Piecemeal necrosis | ± | ± | ± | ++ |
Cholangiolar proliferation | ± | ++ | − | + |
Cholestasisc | C | − | C | P, C |
With copper deposition | None | None | None | +++ |
Arterial lesionsd | Inflammatory or necrotizing | None | SIFC, T | IS |
Venous lesionse | SEL | None | SIFC, CVS | PVT |
Nature of inflammation: L = lymphocytic/monocytic; G = granulomatous; P = plasmacytic.
S = small (<50 µm); M = medium (≥75 µm); L = hilar excretory ducts. Listed in order of prevalence.
Location of cholestasis: C = central; P = peripheral/paraseptal.
SIFC = subintimal foam cells; IS = intimal sclerosis; T = thrombosis.
SEL = subendothelial lymphocytes; CVS = central vein sclerosis; PVT = portal vein thrombi.